These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19674320

  • 1. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [Abstract] [Full Text] [Related]

  • 2. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 4. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 6. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 7. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K.
    Am J Nephrol; 2011 Nov; 34(3):233-40. PubMed ID: 21778707
    [Abstract] [Full Text] [Related]

  • 8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Nov; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 9. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Nov; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 10. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
    Suzuki S, Joh K.
    Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
    [Abstract] [Full Text] [Related]

  • 11. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [Abstract] [Full Text] [Related]

  • 12. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Mar; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 13. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.
    Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY.
    Am J Kidney Dis; 2012 Jan; 59(1):67-74. PubMed ID: 22019331
    [Abstract] [Full Text] [Related]

  • 14. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.
    Gutiérrez E, González E, Hernández E, Morales E, Martínez MA, Usera G, Praga M.
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):51-7. PubMed ID: 17699387
    [Abstract] [Full Text] [Related]

  • 15. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
    Kawaguchi T, Ieiri N, Yamazaki S, Hayashino Y, Gillespie B, Miyazaki M, Taguma Y, Fukuhara S, Hotta O.
    Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
    [Abstract] [Full Text] [Related]

  • 16. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
    Ren Fail; 2005 Feb; 27(1):45-52. PubMed ID: 15717634
    [Abstract] [Full Text] [Related]

  • 17. [Clinico-pathological features and outcome in adult patients with Henoch-Schönlein purpura nephritis].
    Tsuruta Y, Takei T, Takano M, Sawara Y, Aoki A, Eguchi A, Kojima C, Moriyama T, Itabashi M, Sugiura H, Tsukada M, Ogawa T, Yoshida T, Uchida K, Tsuchiya K, Nitta K.
    Nihon Jinzo Gakkai Shi; 2010 Feb; 52(1):51-7. PubMed ID: 20166542
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN, Lai FM, Ho CP, Chan KW.
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [Abstract] [Full Text] [Related]

  • 19. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy.
    Abe T, Kida H, Yoshimura M, Yokoyama H, Koshino Y, Tomosugi N, Hattori N.
    Clin Nephrol; 1986 Jan; 25(1):37-41. PubMed ID: 3955907
    [Abstract] [Full Text] [Related]

  • 20. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients.
    Tanaka M, Yamada S, Iwasaki Y, Sugishita T, Yonemoto S, Tsukamoto T, Fukui S, Takasu K, Muso E.
    Nephron Clin Pract; 2009 Jan; 112(2):c71-8. PubMed ID: 19390205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.